OKYO
OKYO Pharma Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.40
−0.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.96x
- Price / sales
- —
- Price / cash flow
- -12.38x
Enterprise value
- Enterprise value
- $52.9M
- EV / sales
- —
- EV / EBITDA
- -5.75x
- EV / EBIT
- -5.75x
- Market cap
- $73.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026